查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732945

人造血管市場－全球產業規模、佔有率、趨勢、機會及預測（按應用、按聚合物、按地區及競爭細分，2020-2030 年）

Artificial Blood Vessels Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Application, By Polymer, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球人工血管市場價值為 3.0158 億美元，預計到 2030 年將達到 4.2151 億美元，預測期內複合年成長率為 5.74%。該市場是醫療器材產業的一個重要領域，專注於治療心血管和血管疾病的血管移植的開發和應用。人工血管，包括合成的和組織工程的，對於搭橋手術、血液透析通路和主動脈修復等救生手術來說都是不可或缺的，尤其是在天然血管不適合或無法使用的情況下。該領域在材料科學和移植物設計方面取得了顯著進步，提高了安全性、耐用性和手術效果。此外，微創手術的轉變加速了對先進血管移植的需求，從而減少了恢復時間和手術風險，為市場持續成長奠定了基礎。

市場概覽
預測期 2026-2030
2024年市場規模 3.0158億美元
2030年市場規模 4.2151億美元
2025-2030 年複合年成長率 5.74%
成長最快的領域 主動脈疾病
最大的市場 北美洲

關鍵市場促進因素

心血管疾病盛行率上升

主要市場挑戰

監管障礙和核准流程

主要市場趨勢

可生物分解和生物工程材料

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球人造血管市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依應用（主動脈疾病、周邊動脈疾病、血液透析）
    • 依聚合物（聚二噁烷酮、彈性體、聚對苯二甲酸乙二酯、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美人造血管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲人造血管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太人造血管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲人造血管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲人造血管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球人造血管市場：SWOT 分析

第 14 章：競爭格局

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16268

The Global Artificial Blood Vessels Market was valued at USD 301.58 million in 2024 and is projected to reach USD 421.51 million by 2030, expanding at a CAGR of 5.74% during the forecast period. This market represents a vital segment of the medical device industry, focusing on the development and application of vascular grafts for treating cardiovascular and vascular conditions. Artificial blood vessels, both synthetic and tissue-engineered, are integral to life-saving procedures such as bypass surgeries, hemodialysis access, and aortic repair, especially when natural vessels are unsuitable or unavailable. The sector has seen notable advancements in material science and graft design, enhancing safety, durability, and surgical outcomes. Additionally, the shift towards minimally invasive procedures has accelerated demand for advanced vascular grafts that reduce recovery times and procedural risks, positioning the market for sustained growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 301.58 Million
Market Size 2030USD 421.51 Million
CAGR 2025-20305.74%
Fastest Growing SegmentAortic Disease
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The escalating incidence of cardiovascular diseases-such as coronary artery and peripheral arterial diseases-serves as a major catalyst for the artificial blood vessels market. This rise is driven by sedentary lifestyles, increased consumption of processed foods, and a surge in obesity and diabetes, all contributing to vascular complications. The global trend of aging populations further exacerbates vulnerability to arterial disorders due to natural physiological changes. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths annually, highlighting the urgent need for advanced vascular solutions. A hereditary predisposition to heart disease and the health impacts of urbanization, including pollution and stress, also heighten the need for effective interventions like artificial grafts, thereby stimulating market growth.

Key Market Challenges

Regulatory Hurdles and Approval Processes

One of the major challenges facing the artificial blood vessels market is navigating the stringent regulatory frameworks required for medical device approval. Compliance with rigorous standards from authorities such as the FDA and EMA involves lengthy and costly clinical evaluations, often delaying product launches. These regulatory procedures can vary significantly across regions, complicating global distribution strategies. Additionally, the focus on patient safety means that any adverse events or safety concerns can trigger intensified scrutiny, potential recalls, and prolonged approval timelines, thereby impeding market entry and expansion.

Key Market Trends

Biodegradable and Bioengineered Materials

A significant trend in the artificial blood vessels market is the adoption of biodegradable and bioengineered materials that emulate the characteristics of natural vessels. These innovations enhance biocompatibility and minimize risks of clotting or immune reactions. Designed to gradually dissolve and integrate with patient tissue, these materials can help reduce long-term complications such as graft failure or calcification. Moreover, their customizable nature allows for tailored solutions that align with individual patient anatomies, improving fit and performance while reducing the risk of rejection, thus paving the way for personalized vascular care.

Key Market Players

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

Report Scope:

In this report, the Global Artificial Blood Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Blood Vessels Market, By Application:

  • Aortic Disease
  • Peripheral Artery Disease
  • Haemodialysis

Artificial Blood Vessels Market, By Polymer:

  • Polydioxanone
  • Elastomer
  • Polyethylene Terephthalate
  • Others

Artificial Blood Vessels Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Blood Vessels Market.

Available Customizations:

Global Artificial Blood Vessels market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Blood Vessels Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Aortic Disease, Peripheral Artery Disease, Haemodialysis)
    • 5.2.2. By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Blood Vessels Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Polymer
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Blood Vessels Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Polymer
    • 6.3.2. Canada Artificial Blood Vessels Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Polymer
    • 6.3.3. Mexico Artificial Blood Vessels Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Polymer

7. Europe Artificial Blood Vessels Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Polymer
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Blood Vessels Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Polymer
    • 7.3.2. United Kingdom Artificial Blood Vessels Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Polymer
    • 7.3.3. Italy Artificial Blood Vessels Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Polymer
    • 7.3.4. France Artificial Blood Vessels Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Polymer
    • 7.3.5. Spain Artificial Blood Vessels Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Polymer

8. Asia-Pacific Artificial Blood Vessels Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Polymer
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Artificial Blood Vessels Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Polymer
    • 8.3.2. India Artificial Blood Vessels Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Polymer
    • 8.3.3. Japan Artificial Blood Vessels Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Polymer
    • 8.3.4. South Korea Artificial Blood Vessels Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Polymer
    • 8.3.5. Australia Artificial Blood Vessels Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Polymer

9. South America Artificial Blood Vessels Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Polymer
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Artificial Blood Vessels Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Polymer
    • 9.3.2. Argentina Artificial Blood Vessels Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Polymer
    • 9.3.3. Colombia Artificial Blood Vessels Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Polymer

10. Middle East and Africa Artificial Blood Vessels Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Polymer
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Artificial Blood Vessels Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Polymer
    • 10.3.2. Saudi Arabia Artificial Blood Vessels Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Polymer
    • 10.3.3. UAE Artificial Blood Vessels Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Polymer

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Artificial Blood Vessels Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. B. Braun Melsungen
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Becton, Dickinson and Company
  • 14.3. Cook Medical Incorporated
  • 14.4. Humacyte Inc.
  • 14.5. Jotec GmbH
  • 14.6. LeMaitre Vascular Inc
  • 14.7. Medtronic Inc
  • 14.8. Techshot Inc
  • 14.9. Terumo Medical Corporation
  • 14.10. W. L. Gore & Associates, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer